قارن بين أفضل أطباء السرطان الغدي والأسعار في إسرائيل. اعثر على أفضل تطابق لك هنا.
سنختار لك أفضل الأطباء حسب احتياجاتك وميزانيتك.
تمت مراجعة المقالة طبيا من قبل فهد مولود
محرر طبي وعالم بياناتأفضل الأطباء
1
إسرائيل
التقييمات
14000+
من مرضى حقيقيين
احصل على خطط علاجية مخصصة مجانية واختر أفضل خيار. بدون التزام · بدون دفعات لخدماتنا
الدكتورة كارين دروميا هي اختصاصية في العلاج الإشعاعي وطبيبة أورام في مركز رمبام الطبي، تركز على خطط علاجية دقيقة وفعالة.
قد يكون اختيار العيادة في الخارج أمرًا مرهقًا. في Bookimed، حيث ساعدنا أكثر من 800 ألف مريض، نحن نتفهم مخاوفك. نعرف كيفية العثور على الأطباء الموثوقين، وأفضل خيارات الجودة والسعر، وحلول حتى للحالات المعقدة. نحن هنا لإرشادك في كل خطوة على الطريق.
Yan Matsiivskiy
رئيس فريق المنسق الطبي
تم توجيه أكثر من 4300+ رحلة مرضى
3 سنة في Bookimed
142 مريض من Israel وجدوا طبيبهم عبرنا هذا الشهر
اختبار لمدة دقيقتين
أخبرنا بهدفك، ميزانيتك، وخطتك الزمنية
مطابقة بشرية + ذكاء اصطناعي
يجد خوارزمينا التطابقات، ويؤكد المنسق مدى الملاءمة
خياراتك جاهزة
قارن الأسعار، الباقات، والتواريخ. تحدث مع منسقك
تشعر بالحيرة لكثرة الخيارات؟
يوجه علاجك
منسقون شخصيون مدربون طبياً
| الترتيب. | طبيب | خبرة | مناسب لـ | ما الذي يميزهم عن غيرهم | العيادة والموقع | الاستشارة |
|---|---|---|---|---|---|---|
| #1 | العلاج الإشعاعي للسرطان الغدي | متخصص في العلاج الإشعاعي - يقدم خطط علاجية دقيقة مصممة خصيصاً لسرطان الغدد (adenocarcinoma). يعمل في مركز رمبام الطبي، وهو مرفق رعاية صحية من الطراز الأول. | إسرائيل | السعر عند الطلب |
Top specialists for adenocarcinoma in Israel include Dr. Ofer Merimsky, Dr. Pelles Sharon, and Dr. David Sarid at Sourasky Medical Center. These experts hold board certifications in oncology and lead specialized departments focused on lung, pancreatic, and gastric malignancies using immunotherapy and complex surgical techniques.
Bookimed Expert Insight: Many leading Israeli oncologists like Dr. David Sarid and Dr. Pelles Sharon serve as principal investigators for clinical trials. This is vital because it gives patients access to experimental protocols before they become standard globally. Choosing a doctor involved in research often means access to newer immunotherapy or targeted drugs.
Patient Consensus: Patients are often struck by the efficiency of diagnostic centers where multiple tests are performed in one afternoon. Many mention that staying at hotels near the hospital made it easier to manage intensive treatment schedules.
To get a second opinion from a top Israeli adenocarcinoma doctor, choose specialists like Dr. Ofer Merimsky at Sourasky Medical Center. Focus on board-certified oncologists with international fellowships and leadership roles in national cancer councils to ensure high-level expertise for complex case reviews.
Bookimed Expert Insight: Top Israeli oncologists often hold dual roles as researchers and department heads. Dr. David Sarid is a principal investigator for clinical trials at Sourasky Medical Center. Choosing a doctor involved in active research typically provides access to newer biological and targeted therapies not yet widely available.
Patient Consensus: Patients recommend sending biopsy slides and imaging discs for a remote review before traveling. Many noted that a pathology re-review frequently refined their diagnosis and changed their initial treatment plan.
Israeli oncologists specialize in specific adenocarcinoma subtypes like gastric or lung cancer through organ-focused departments. Experts such as Dr. Ofer Merimsky focus on thoracic oncology for lung cases. Others like Dr. Pelles Sharon specialize in abdominal cancers including gastric and pancreatic tumors.
Bookimed Expert Insight: Israeli oncology leadership is highly technical. For example, Dr. Ido Wolf chairs the National Oncology Council. Choosing a department head like Dr. Wolf or Dr. Ofer Merimsky at Sourasky Medical Center provides access to specialists who define national treatment protocols for complex adenocarcinoma cases.
Patient Consensus: Patients recommend checking if your doctor leads a dedicated unit for your specific organ. They often feel more confident knowing a multidisciplinary tumor board reviews their imaging before starting surgery. Confirming if a surgeon frequently performs robotic or laparoscopic procedures for your direct cancer type is also a top priority.
International patients seeking adenocarcinoma treatment in Israel can typically see a specialist within 1 to 3 weeks. Urgent cases receive priority scheduling through dedicated hospital offices. Board-certified oncologists like Dr. Ofer Merimsky and Dr. Ido Wolf at Sourasky Medical Center provide rapid case reviews and second opinions.
Bookimed Expert Insight: Patients who accept the first available slot at major centers like Sourasky or Assuta see specialists fastest. While a specific senior professor might have a month-long wait, opting for a department head like Dr. Ella Tepper can accelerate the diagnostic start date.
Patient Consensus: Patients found that having biopsy results ready beforehand moved their timeline from weeks to days. They mentioned that direct hospital coordination revealed urgent appointment slots that were not visible on standard online booking systems.
Most Israeli oncology specialists speak fluent English and use it daily for medical research and international collaborations. Many doctors hold fellowships from major centers in the USA and UK, such as Oxford University or New York Hospital, ensuring high proficiency during complex adenocarcinoma consultations.
Bookimed Expert Insight: Israeli oncology infrastructure favors English because doctors use Western research protocols to treat adenocarcinoma. Specialists at Sourasky Medical Center often lead international clinical trials, which requires them to maintain high English standards for data accuracy. For a second opinion, patients often choose specialists like Dr. Ido Wolf, who has extensive experience in both Israeli and American medical systems.
Patient Consensus: Patients often find that while senior specialists speak English fluently, having written questions helps during stressful cancer discussions. Bringing a companion or arranging for a translator can help clarify technical details shared by nursing or administrative staff.
Israel offers numerous clinical trials for adenocarcinoma, led by principal investigators like Dr. David Sarid and Dr. Ari Raphael at Sourasky Medical Center. These trials focus on advanced immunotherapies, genomic profiling, and targeted drug combinations for lung, prostate, and digestive tract cancers.
Bookimed Expert Insight: Patients can access groundbreaking trials specifically for adenocarcinoma by targeting specialists like Dr. Ari Raphael, who leads the National Genomic Medicine Initiative. This integration of national genomics with early-phase trials at Sourasky Medical Center provides faster access to molecularly targeted therapies not yet available on the standard market.
Patient Consensus: Patients receiving treatment often find that starting with genomic profiling early helps them enter clinical trials faster. Those traveling to Israel noted that having coordinators manage tissue shipping significantly reduced their wait times for finding appropriate study groups.